A Study With Technolas® TENEO 317 Model 2 Excimer Laser to Treat Participants With Myopia or Myopic Astigmatism
Public ClinicalTrials.gov record NCT04111757. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism
Study identification
- NCT ID
- NCT04111757
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Bausch & Lomb Incorporated
- Industry
- Enrollment
- 168 participants
Conditions and interventions
Conditions
Interventions
- Technolas® TENEO 317 Model 2 Device
Device
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 24, 2019
- Primary completion
- Aug 5, 2021
- Completion
- Aug 5, 2021
- Last update posted
- Jun 13, 2024
2019 – 2021
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bausch Site 101 | Newport Beach | California | 92663 | — |
| Bausch Site 110 | Blaine | Minnesota | 55434 | — |
| Bausch Site 107 | Bloomington | Minnesota | 55420 | — |
| Bausch Site 108 | Omaha | Nebraska | 68105 | — |
| Bausch Site 106 | Portsmouth | New Hampshire | 03801 | — |
| Bausch Site 102 | Amherst | New York | 14228 | — |
| Bausch Site 104 | Greensboro | North Carolina | 27401 | — |
| Bausch Site 103 | Mt. Pleasant | South Carolina | 29464 | — |
| Bausch Site 109 | Sioux Falls | South Dakota | 57108 | — |
| Bausch Site 105 | Cedar Park | Texas | 78613 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04111757, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 13, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04111757 live on ClinicalTrials.gov.